poisar

Stocks · News reference

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks Delivering High-Dividend Yields

BenzingaAvi Kapoor

Analysts review high-yield healthcare stocks CVS, Viatris and Medtronic, citing ratings, price targets, dividend yields and recent company news.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchZacks.Com

    CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors

    CVS Health stock declined 1.4% to $87.60, underperforming the broader market which gained 1.49%. The stock has fallen 4.49% over the past month. The company is expected to report flat EPS of $1.6 for the upcoming quarter with revenue projected at $105.04 billion (up 2.11% YoY). CVS holds a Zacks Rank #3 (Hold) rating and trades at a Forward P/E of 11.07, below its industry average of 17.31.

  2. Globenewswire IncResearchandmarkets.Com

    Cardiorespiratory Assessment Units Market Poised for Growth Through 2035 as Advanced Technologies and Expanding Clinical Applications Create New Opportunities

    The global Cardiorespiratory Assessment Units Market is projected to grow from USD 1.48 billion in 2025 to USD 2.98 billion by 2035, expanding at a CAGR of 7.23%. Growth is driven by rising prevalence of COPD and heart failure, innovation in portable AI-enabled systems, and expanding remote care applications. However, high equipment costs and staffing requirements remain challenges. North America leads with 35.12% market share.

  3. Globenewswire IncResearchandmarkets.Com

    Mexico Cardiac Rhythm Management Devices Market Outlook to 2036 Provides Revenue, Volume, Pricing and Competitive Insig

    ResearchAndMarkets.com released a comprehensive market report on Mexico's cardiac rhythm management devices sector, covering CRT, ICDs, and pacemakers through 2036. The report provides revenue forecasts, sales volume data, pricing analysis, and 2025 competitive positioning for major market players, supporting strategic decision-making for manufacturers, investors, and healthcare stakeholders.

  4. The Motley FoolProsper Junior Bakiny

    2 Beaten-Down Stocks to Buy Before They Bounce Back

    Shopify and Intuitive Surgical, despite significant year-to-date declines of 19% and 29% respectively, present attractive buying opportunities. Shopify's strong Q2 results and AI-powered initiatives position it well in e-commerce, while Intuitive Surgical's market leadership in robotic-assisted surgery and high switching costs provide competitive advantages despite increased competition from Medtronic.